Condition
AIDS-Related Plasmablastic Lymphoma
ClinicalTrials.gov condition label
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov condition label, found in 2 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
2 shownGene Therapy and Combination Chemotherapy in Treating Patients With AIDS-Related Non-Hodgkin LymphomaNCT02337985 · 2015-11-20
ACTIVE_NOT_RECRUITINGVorinostat and Combination Chemotherapy With Rituximab in Treating Patients With HIV-Related Diffuse Large B-Cell Non-Hodgkin Lymphoma or Other Aggressive B-Cell LymphomasNCT01193842 · 2010-10-06
COMPLETEDCommon interventions
CyclophosphamideDRUG2Doxorubicin HydrochlorideDRUG2EtoposideDRUG2PrednisoneDRUG2RituximabBIOLOGICAL2Vincristine SulfateDRUG2FilgrastimBIOLOGICAL1Laboratory Biomarker AnalysisOTHER1Lentivirus Vector rHIV7-shI-TAR-CCR5RZ-transduced Hematopoietic Stem/Progenitor CellsBIOLOGICAL1Pharmacological StudyOTHER1VorinostatDRUG1
Leading sponsors
Trial status mix
ACTIVE_NOT_RECRUITING1
COMPLETED1
Phase mix
PHASE12
PHASE21
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.